Trial site
Miriam Hospital
Providence, Rhode Island 02906, United StatesNot linked to an institution yet
- 19running trials
- 9closed trials
The trials here
What the 30 trials at this site are about, from their registry records.
- Phase
- Phase 316 trials
- Phase 23 trials
- Phase 11 trial
- Status
- Active, not recruiting15 trials
- Completed8 trials
- Recruiting3 trials
- Suspended2 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- National Cancer Institute (NCI)10 trials
- Alliance for Clinical Trials in Oncology5 trials
- California Polytechnic State University-San Luis Obispo2 trials
- M.A. Med Alliance S.A.2 trials
- Acotec Scientific Co., Ltd1 trial
- and 10 more
Running trials
Recruiting
Lifestyle Interventions to Prevent Diabetes in U.S. Home Visiting Programs
NCT06988306· California Polytechnic State University-San Luis Obispo· Source
Contact: Rena R Wing, PhD
Active, not recruiting
A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.
NCT06447662· Phase 1· Pfizer· Source
Active, not recruiting
A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC
NCT05968326· Phase 2· Genentech, Inc.· Source
Recruiting
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
NCT05929768· Phase 3· SWOG Cancer Research Network· Source
Contact: Mary Anne Fenton (principal investigator)
Active, not recruiting
SELUTION4SFA Trial
NCT05132361· M.A. Med Alliance S.A.· Source
Recruiting
SELUTION4BTK Trial
NCT05055297· M.A. Med Alliance S.A.· Source
Contact: MedAlliance Clinical Team
Recruiting
Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
NCT04798261· Penumbra Inc.· Source
Contact: Joanne Krasnoff
Active, not recruiting
Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer
NCT04094688· Phase 3· Alliance for Clinical Trials in Oncology· Source
Active, not recruiting
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
NCT03055013· Phase 3· National Cancer Institute (NCI)· Source
Active, not recruiting
Breast Cancer WEight Loss Study (BWEL Study)
NCT02750826· Phase 3· Alliance for Clinical Trials in Oncology· Source
Active, not recruiting
Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
NCT02506153· Phase 3· National Cancer Institute (NCI)· Source
Active, not recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
NCT02465060· Phase 2· National Cancer Institute (NCI)· Source
Active, not recruiting
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
NCT02201992· Phase 3· ECOG-ACRIN Cancer Research Group· Source
Active, not recruiting
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
NCT02193282· Phase 3· National Cancer Institute (NCI)· Source
Active, not recruiting
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
NCT02194738· National Cancer Institute (NCI)· Source
Active, not recruiting
Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
NCT01886872· Phase 3· National Cancer Institute (NCI)· Source
Active, not recruiting
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
NCT01274338· Phase 3· National Cancer Institute (NCI)· Source
Active, not recruiting
Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia
NCT00003861· Alliance for Clinical Trials in Oncology· Source
Active, not recruiting
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
NCT00048958· Alliance for Clinical Trials in Oncology· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error